KLRS- Kalaris Therapeutics, Inc.

Name: Kalaris Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kalaris Therapeutics, Inc. (KLRS) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. KLRS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Akkaraju Srinivas	2.22M	$9.94M	-
CFO	Gall Matthew	235.0K	$1.05M	-

Activity

Buys and sells only

Transactions

10 filings · page 11

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 19, 2023	Brainard Diana85	Chief Executive Officer	Sell	8,408	$3.71	$31,182.75	-0.9%	-8.1%	-80.7%
Feb 21, 2023	Brainard Diana85	Chief Executive Officer	Sell	5,122	$6.63	$33,935.30	-0.5%	-32.4%	-88.9%
Jan 20, 2023	Sinha Vikas84	See Remarks	Sell	6,537	$5.09	$33,287.18	-0.3%	-28.0%	-87.0%
Jan 20, 2023	Hagen Brett R84	Chief Accounting Officer	Sell	1,895	$5.09	$9,644.58	-1.3%	-28.0%	-87.0%
Jan 20, 2023	Miller Edward82	General Counsel	Sell	2,573	$5.09	$13,100.68	-0.9%	-28.0%	-87.0%
Jan 19, 2023	Brainard Diana85	Chief Executive Officer	Sell	34,435	$5.08	$174,850.60	-5.4%	-24.8%	-86.7%
Nov 18, 2022	Brainard Diana85	Chief Executive Officer	Sell	4,515	$7.27	$32,810.05	-0.7%	-16.3%	-77.9%
Nov 16, 2022	Van Beek Jeroen B85	Chief Commercial Officer	Sell	16,074	$7.50	$120,527.67	-4.6%	-12.6%	-78.1%
Nov 14, 2022	Miller Edward82	General Counsel	Sell	2,358	$8.91	$21,018.03	-1.2%	-26.1%	-81.2%
Nov 11, 2022	Van Beek Jeroen B85	Chief Commercial Officer	Sell	36,592	$8.20	$299,904.37	-9.5%	-29.1%	-83.3%

← PrevPage 11Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC